Literature DB >> 12644939

Electronically measured compliance with occlusion therapy for amblyopia is related to visual acuity increase.

Sjoukje E Loudon1, Jan-Roelof Polling, Huibert J Simonsz.   

Abstract

PURPOSE: We set out to determine whether the children who have low compliance (measured electronically) with occlusion therapy for amblyopia are those with insufficient increase of visual acuity.
METHODS: In 14 newly identified amblyopic children (mean age 4.3+/-1.9 years), compliance was measured electronically over a period of 1 week, 6 months after the start of occlusion therapy. Compliance was measured with an Occlusion Dose Monitor (ODM). The measurements took place during planned domiciliary visits. The children were diagnosed with anisometropia (n=5), strabismus (n=4) and anisometropia and strabismus (n=5). Compliance was expressed in percentages of the electronically registered time compared with the prescribed occlusion time. Satisfactory acuity increase following 6 months of occlusion therapy was defined on reaching any of the following criteria: acuity increase expressed as a ratio between acuity of the amblyopic eye and acuity of the good eye of more than 0.75, acuity of the amblyopic eye exceeding 0.5 as measured on the E-Chart or Landolt-C, or three LogMAR lines of increase in acuity.
RESULTS: Measured compliance averaged 80% in the eight children who had a satisfactory acuity increase and 34% in the six children who had an unsatisfactory visual acuity increase. Children with low acuity increase had statistically significantly lower compliance (P=0.038).
CONCLUSION: The general assumption among orthoptists, that compliance with occlusion therapy for amblyopia is low in children with insufficient acuity increase, has been validated by electronic, objective means.

Entities:  

Mesh:

Year:  2003        PMID: 12644939     DOI: 10.1007/s00417-002-0570-z

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  24 in total

1.  Objective survey of the prescription of occlusion therapy for amblyopia.

Authors:  Sjoukje E Loudon; Jan-Roelof Polling; Brigitte Simonsz; Huibert J Simonsz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-09       Impact factor: 3.117

2.  Electronic recording of occlusion treatment for amblyopia: potential of the new technology.

Authors:  Yaroslava Chopovska; Sjoukje E Loudon; Licia Cirina; Alina Zubcov; Huibert J Simonsz; Marc Lüchtenberg; Maria Fronius
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-12-17       Impact factor: 3.117

3.  Occlusion therapy for amblyopia.

Authors:  Sjoukje E Loudon; Huibert J Simonsz
Journal:  BMJ       Date:  2007-10-06

Review 4.  Improving the performance of the amblyopic visual system.

Authors:  Dennis M Levi; Roger W Li
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-02-12       Impact factor: 6.237

5.  Mehdi-ODM; a modified digital monitoring of the occlusion therapy for amblyopia.

Authors:  Amir Hasan Gharebaghi; Fatemeh Heidary; Reza Gharebaghi; Roghayeh Heidary
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-08-18       Impact factor: 3.117

6.  Comparison between over-glasses patching and adhesive patching for children with moderate amblyopia: a prospective randomized clinical trial.

Authors:  Su Jin Kim; Hyeshin Jeon; Jae Ho Jung; Kwang Min Lee; Hee Young Choi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-12-04       Impact factor: 3.117

7.  Photorefractive keratectomy for anisometropic amblyopia in children.

Authors:  Evelyn A Paysse
Journal:  Trans Am Ophthalmol Soc       Date:  2004

8.  Why is compliance with occlusion therapy for amblyopia so hard? A qualitative study.

Authors:  M Dixon-Woods; M Awan; I Gottlob
Journal:  Arch Dis Child       Date:  2006-03-10       Impact factor: 3.791

Review 9.  Amblyopia and binocular vision.

Authors:  Eileen E Birch
Journal:  Prog Retin Eye Res       Date:  2012-11-29       Impact factor: 21.198

Review 10.  The relationship between anisometropia and amblyopia.

Authors:  Brendan T Barrett; Arthur Bradley; T Rowan Candy
Journal:  Prog Retin Eye Res       Date:  2013-06-15       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.